People familiar with the business told the Journal that Kenvue plans to raise $3.5 billion and is meeting with potential investors on April 24.
Kenvue — which makes brands including Band-Aid, Tylenol, Neutrogena and Listerine — generated $14.95 billion in global sales for Johnson & Johnson in 2022.
The New Brunswick, N.J.-based drugmaker first announced the split into two independent companies in November 2021.
The Journal called the share sale the “biggest of what so far has been a quiet year for IPOs.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
